Addition of rapamycin to anti-CD3 antibody improves long-term glycaemia control in diabetic NOD mice.
about
Combination immunotherapies for type 1 diabetes mellitus.Less is more: the detrimental consequences of immunosuppressive therapy in the treatment of type-1 diabetes.Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus.A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
P2860
Addition of rapamycin to anti-CD3 antibody improves long-term glycaemia control in diabetic NOD mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@ast
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@en
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@nl
type
label
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@ast
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@en
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@nl
prefLabel
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@ast
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@en
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@nl
P2093
P2860
P1433
P1476
Addition of rapamycin to anti- ...... control in diabetic NOD mice.
@en
P2093
John Tisdale
Jordan Perlman
Matthew M Hsieh
Oswald Phang
R P Weitzel
Shira Perl
P2860
P304
P356
10.1371/JOURNAL.PONE.0067189
P407
P577
2013-06-24T00:00:00Z